Patient Support Line 1-800-282-7630, Monday – Friday: 9 AM – 5 PM ET
Financial Resources and Saving Options
We’re committed to making treatment with KISQALI as affordable as possible. What you'll pay for your KISQALI prescription depends on a few factors. Visit the Novartis Oncology Patient Support website to get a better idea of what your cost may be.
Read below to learn about ways you may be able to save on your KISQALI prescription, and then see how a Patient Navigator can help simplify this process for you.
Free Trial Offer for KISQALI and/or FEMARA
Patients are eligible to receive a 1-treatment cycle supply of any one of the following at no cost.‡
d. KISQALI + FEMARA
e. KISQALI + letrozole
f. KISQALI FEMARA Co-Pack
Call 1-800-282-7630 or visit www.FreeTreatmentVoucher.com to receive your free trial offer.
The KISQALI FEMARA Co-Pack is a prescription medicine used as the first hormonal-based therapy to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic).
The KISQALI FEMARA Co-Pack contains 2 different types of medicines:
The violet tablet contains the medicine KISQALI.
The yellow tablet contains the medicine FEMARA.
It is not known if KISQALI or the KISQALI FEMARA Co-Pack are safe and effective in children.
‡No purchase required of the KISQALI FEMARA Co-Pack, or KISQALI or FEMARA (including generic letrozole). This offer is available for patients with a valid prescription for the KISQALI FEMARA Co-Pack, or for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product.